home contact us sitemap
A natural drug is a chemical compound or substance produced by a microbe or plant material - found in nature that usually has a specific pharmacological or biological activity for use in drug design.

Sabinsa places itself as a modern scientific company with inherent strength in Research & Development. The R&D efforts in the company took a quantum leap with the grant of ‘drug’ status from the Drug Controller General of India (DCGI) for two of its natural molecules-Forskolin 1% eye drops and BSM cream for Psoriasis. Their description is given below:
Forskolin 1% eye drops is a novel method of treatment for Glaucoma. Glaucoma is known to be the second leading cause for blindness in the world after Cataract. The chronic and progressive nature of ailment and higher cost of treatment compared to other ophthalmological disorders makes it an even more challenging disease segment. Forskolin 1% eye drops (Covered by US Patent no. *US6960300) is a unique topical formulation for the treatment of open angle glaucoma. The molecule is found to be better than Timolol in the reduction of intraocular pressure (IOP) in the eye. The proven efficacy & safety profile of the molecule makes it one of the strongest potential treatments for Glaucoma. Additional clinical documentation on a 2% Forskolin solution for a once a day treatment is approved by DCGI for clinical studies
Forskolin 1% eye drops is a novel method of treatment for Glaucoma. Glaucoma is known to be the second leading cause for blindness in the world after Cataract. The chronic and progressive nature of ailment and higher cost of treatment compared to other ophthalmological disorders makes it an even more challenging disease segment. Forskolin 1% eye drops (Covered by US Patent no. *US6960300) is a unique topical formulation for the treatment of open angle glaucoma. The molecule is found to be better than Timolol in the reduction of intraocular pressure (IOP) in the eye. The proven efficacy & safety profile of the molecule makes it one of the strongest potential treatments for Glaucoma. Additional clinical documentation on a 2% Forskolin solution for a once a day treatment is approved by DCGI for clinical studies


*US6960300 –TITLE: Process for preparing water soluble diterpenes and their applications, producing water solution of forskolin for pharmaceutical, nutraceutical or cosmetic use.
These statements have not been evaluated by the Food and Drug Administration.
These products are not intended to diagnose, treat, cure, or prevent any disease.
The above listed Drugs are Approved by the Drug Controller General of India.
Approval in other countries are awaited.
The products offered by Sabinsa Corporation are certified Kosher, with many certified Halal.
인증서를 보고 싶으시면
이곳을 클릭 하십시요
  인증서를 보고 싶으시면
이곳을 클릭 하십시요